首页> 外国专利> SYNERGISTIC INDUCTION OF HUMORAL AND CELLULAR IMMUNITY BY COMBINATORIAL ACTIVATION OF TOLL-LIKE RECEPTORS

SYNERGISTIC INDUCTION OF HUMORAL AND CELLULAR IMMUNITY BY COMBINATORIAL ACTIVATION OF TOLL-LIKE RECEPTORS

机译:像Toll样受体的组合激活协同诱导人体和细胞免疫

摘要

Described herein are compositions that include a selected antigen, a TLR4 ligand and a TLR7/TLR8 ligand, wherein the antigen and TLR ligands are encapsulated in nanoparticles. Co-administration of both a TLR4 ligand and a TLR7/TLR8 ligand results in the synergistic induction of humor and cellular immunity as evidenced by an increase in pro-inflammatory cytokine production, an increase in the number of CD8+ T effector and T memory cells, an increase in titer of antigen-specific antibodies, an increase in antibody affinity, an increase in the proliferation of naïve B cells and/or a significant enhancement in the persistence of antibody and T cell responses. The compositions and methods provided herein can be used to stimulate an immune response such as an immune response to a pathogen or a tumor.
机译:本文描述了包含所选抗原,TLR4配体和TLR7 / TLR8配体的组合物,其中抗原和TLR配体被封装在纳米颗粒中。 TLR4配体和TLR7 / TLR8配体的共同给药可共同诱导体液和细胞免疫,如促炎性细胞因子产生的增加,CD8 + T效应子和T记忆细胞的数量增加所证明的,抗原特异性抗体效价的提高,抗体亲和力的提高,未成熟B细胞的增殖的提高和/或抗体和T细胞反应的持久性的显着提高。本文提供的组合物和方法可用于刺激免疫应答,例如对病原体或肿瘤的免疫应答。

著录项

  • 公开/公告号EP2303236A2

    专利类型

  • 公开/公告日2011-04-06

    原文格式PDF

  • 申请/专利权人 EMORY UNIVERSITY;

    申请/专利号EP20090774459

  • 申请日2009-07-01

  • 分类号A61K9/16;A61K47/34;A61P35;A61K39/145;A61K39/29;

  • 国家 EP

  • 入库时间 2022-08-21 17:54:48

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号